Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1476
LendingTree
TREE
$348M
| $6.52M | 0.01% |
22,534
-38,000
| -63% | -$9.18M |
2019 Q2
4 quarters
|
|
1477
Gencor Industries
GENC
$267M
| $6.48M | 0.01% |
512,947
+32,300
| +7% | +$374K |
2013 Q2
28 quarters
|
|
1478
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.53B
| $6.46M | 0.01% |
57,900
+29,400
| +103% | +$3.22M |
2019 Q1
5 quarters
|
|
1479
Commercial Vehicle Group
CVGI
$114M
| $6.43M | 0.01% |
2,226,181
-290,687
| -12% | -$604K |
2015 Q3
19 quarters
|
|
1480
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
| $6.43M | 0.01% |
193,500
+87,200
| +82% | +$2.89M |
2020 Q1
1 quarter
|
|
|
AEGN
1481
DELISTED
Aegion Corp
AEGN
| $6.42M | 0.01% |
404,296
-54,704
| -12% | -$814K |
2015 Q1
21 quarters
|
|
|
CNCE
1482
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $6.41M | 0.01% |
644,000
+29,000
| +5% | +$278K |
2015 Q4
18 quarters
|
|
1483
DELISTED
Healthcare Realty Trust Incorporated
HR
| $6.41M | 0.01% |
218,700
-55,900
| -20% | -$1.67M |
2020 Q1
1 quarter
|
|
|
RVLP
1484
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $6.4M | 0.01% |
951,307
-71,400
| -7% | -$349K |
2019 Q2
4 quarters
|
|
1485
DHI Group
DHX
$215M
| $6.4M | 0.01% |
3,047,778
+29,878
| +1% | +$76.8K |
2013 Q3
27 quarters
|
|
1486
National Fuel Gas
NFG
$7.71B
| $6.39M | 0.01% |
+152,300
| New | +$6.22M |
2020 Q2
0 quarters
|
|
1487
Designer Brands
DBI
$300M
| $6.38M | 0.01% |
942,130
+434,914
| +86% | +$2.63M |
2018 Q1
9 quarters
|
|
|
PFSW
1488
DELISTED
PFSweb, Inc.
PFSW
| $6.37M | 0.01% |
953,700
+229,930
| +32% | +$1.22M |
2013 Q2
28 quarters
|
|
1489
Schrodinger
SDGR
$1.94B
| $6.36M | 0.01% |
+69,500
| New | +$4.05M |
2020 Q2
0 quarters
|
|
1490
Zepp Health
ZEPP
$52.1M
| $6.35M | 0.01% |
128,476
-8,235
| -6% | -$380K |
2018 Q3
7 quarters
|
|
1491
LSI Industries
LYTS
$788M
| $6.33M | 0.01% |
979,141
-129,630
| -12% | -$748K |
2015 Q2
20 quarters
|
|
1492
Fossil Group
FOSL
$423M
| $6.33M | 0.01% |
1,361,050
+1,071,155
| +369% | +$4.11M |
2018 Q2
8 quarters
|
|
1493
Heritage Insurance Holdings
HRTG
$1.08B
| $6.3M | 0.01% |
481,100
+27,800
| +6% | +$325K |
2018 Q3
7 quarters
|
|
1494
CAE Inc
CAE
$7.55B
| $6.29M | 0.01% |
388,619
-890,027
| -70% | -$13.8M |
2013 Q2
28 quarters
|
|
1495
JELD-WEN Holding
JELD
$120M
| $6.28M | 0.01% |
390,088
-384,600
| -50% | -$5.07M |
2019 Q1
5 quarters
|
|
|
EXPR
1496
DELISTED
Express, Inc.
EXPR
| $6.28M | 0.01% |
203,905
-18,560
| -8% | -$684K |
2018 Q1
9 quarters
|
|
1497
Dell
DELL
$364B
| $6.28M | 0.01% |
+225,469
| New | +$5.07M |
2020 Q2
0 quarters
|
|
1498
DELISTED
Select Medical
SEM
| $6.26M | 0.01% |
789,357
-1,570,918
| -67% | -$13M |
2019 Q1
5 quarters
|
|
|
MAXR
1499
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $6.25M | 0.01% |
348,202
-100,027
| -22% | -$1.29M |
2019 Q4
2 quarters
|
|
1500
Atlanta Braves Holdings Series A
BATRA
$3.7B
| $6.25M | 0.01% |
311,400
+39,300
| +14% | +$798K |
2017 Q1
13 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.